Recon: Verastem's ovarian cancer drug gets FDA approval; PhRMA blasts tariffs as industry trade probe comments end
ReconJason Scott
Biologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States